Managing Chronic Tendon Pain by Metformin

Last updated: June 2, 2025
Sponsor: James Wang
Overall Status: Active - Recruiting

Phase

1

Condition

Chronic Pain

Pain

Sprains

Treatment

Placebo

Metformin

Clinical Study ID

NCT06100822
STUDY23040151
HT9425-23-1-0712
  • Ages 18-50
  • All Genders

Study Summary

The purpose of the current exploratory clinical trial is to determine the effect of oral ingestion of metformin (OIM) in non-diabetic patients with chronic Achilles tendon pain. The trial has two aims; 1) to assess the effects of OIM treatment on tendon pain, and 2) to determine the effects of OIM capsules on tendon healing and repair. Twenty participants will be treated with metformin capsules for 16 weeks combined with a home exercise program. A comparison group of 20 participants will be treated with placebo tablets along with home exercise program.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Willing and able to provide informed consent for participation

  • Clinical diagnosis of Achilles tendinopathy

  • Pain disability index score of between 20 - 70 points (0-100 scale VISA-A)

  • Sonopalpation tenderness with tendon thickening and/or loss of fibrillaryarchitecture.

  • Ability to read, speak, and understand English

Exclusion

Exclusion Criteria:

  • Any intervention (corticosteroids or other orthobiologic intervention as injection)to targeted tissue within the last 6 months.

  • Previous Achilles tendon surgery.

  • Known platelet abnormality or hematological disorder.

  • Presence of other conditions that might affect the functional scale of the indexedlimb.

  • Unwillingness to be randomized.

  • Body Mass Index (BMI) greater than 30.

  • Occult tear in the indexed tendon.

  • Systemic inflammatory disease.

  • Use of fluoroquinolone in the past 6 months.

  • Subjects must not be pregnant or breastfeeding, or planning to become pregnant orbreastfeed during the course of the trial

  • Chronic kidney disease (eGFR <60)

  • Diagnosis of diabetes mellitus or elevated HbA1c at screening (> 6.5)

  • Unable to take an oral medication in a non crushable pill form

  • Taking metformin presently or within the last 6 months

  • History of allergy to metformin

  • History of lactic acidosis or elevated lactate at screening (> 2.2)

  • Severe Hepatic dysfunction

  • Currently taking a diabetic medication such as sitagliptin, saxagliptin,linagliptin, alogliptin, sitagliptin with metformin

  • Currently taking a Carbonic anhydrase inhibitor such as topiramate, zonisamide,acetazolamide, dichlorphenamide, methazolamide

  • Currently taking cimetidine

Study Design

Total Participants: 40
Treatment Group(s): 2
Primary Treatment: Placebo
Phase: 1
Study Start date:
May 24, 2024
Estimated Completion Date:
August 31, 2025

Study Description

This is a blinded and randomized controlled trial that focuses on the treatment effects of metformin (Met) on chronic tendon pain, healing, and repair in midportion Achilles tendinopathy. We will include a total 40 patients randomly divided into two equal groups:

Group 1: Home Exercise Program + Placebo as a control group

Group 2: Home Exercise Program + Oral Ingestion of Metformin

Patients in group 1 will receive placebo capsules,1 capsule (500 mg) daily for week one, 2 capsules (1,000 mg) daily for week two, 3 capsules daily for week 3 (1,500 mg), and 4 capsules daily (2,000 mg) for weeks 4-16. Patients in group 2 will receive metformin capsules,1 capsule (500 mg) daily for week one, 2 capsules (1,000 mg) daily for week two, 3 capsules daily for week 3 (1,500 mg), and 4 capsules daily (2,000 mg) for weeks 4-16. All patients will participate in a home exercise program through MedBridge, a HIPAA-compliant participant portal currently used by physical therapists at University of Pittsburgh Medical Center. There are 3 visits for this study. Visits include a Screening/Baseline visit, week 4 and week 16 visit. During each visit, participants will answer questions, complete functional testing, and undergo an ultrasound of the Achilles Tendon.

Connect with a study center

  • University of Pittsburgh

    Pittsburgh, Pennsylvania 15213
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.